Global Immunohistochemistry Market – Industry Analysis and Forecast (2019-2027) –by Product, Application, End User and Region.

Global Immunohistochemistry Market was valued at US$ 1.9Bn in 2019 and is expected to reach US$ 3.2.Bn by 2027, at a CAGR of 8.23% during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report

Global Immunohistochemistry Market Dynamics:

Global immunohistochemistry (IHC) market is witnessing significant growth owing to increasing geriatric population, growing healthcare expenditure and increasing awareness about histopathology. Also, the growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases is supporting the growth of the immunohistochemistry market. The rapid growth in emerging economies and technological development in the in vitro diagnostics industry is likely to create opportunities for the manufacturers of immunohistochemistry kit, equipment and reagent. However, the high cost of IHC equipment is the key factor hindering the growth of the global market. A significant ascent in healthcare spending and move in the spotlight on esteem based medicinal services arrangements can also prompt development of the immunohistochemistry showcase over the gauge time frame. As specified by the Centers of Medicare and Medicaid Services (CMS) projections, the National Health Expenditure is forecast to ascend at a normal of 5.5% consistently from 2019 to 2027. It is relied upon to stretch around US$ 5.7 trillion by 2027. Clinics and care offices are implementing an increasingly explicit and focused treatment for good results and to build up a move esteem based healthcare conveyance. Antibodies segment dominated the market because of important market drivers such as growing demand for personalized medication and technological advancement in biological for the treatment of chronic diseases. Cancer is dominating a segment of the immunohistochemistry market, by an application. The large share of diagnostic application in cancer diseases can be attributed to the rising prevalence of cancer, rapidly growing geriatric population in developed countries.

Global Immunohistochemistry Market Regional Analysis:

North America accounted for the major share of the global immunohistochemistry market, followed by Europe and the Asia-Pacific. Growth in the developed markets like North America and Europe is mostly driven by the well-established healthcare industry, easy accessibility to advanced technologies, and increasing opportunities for advanced cancer diagnostic testing and cancer screening. North America Immunohistochemistry Market was worth US$ 530Mn in 2019 and estimated to be growing at a CAGR of 7.6%. Europe has been the second largest market for immunohistochemistry, where the market is driven by the presence of a large pool of cancer patients, growing healthcare expenditure and rapidly developing healthcare infrastructure. The Europe Immunohistochemistry Market was worth US$ 440Mn in 2019 and estimated to be increasing at a CAGR of 7.45%. In 2019, Germany lead the European immunohistochemistry market and it is also expected to grow at the fastest rate in Europe, during the forecast period. Various players are operating in global immunohistochemistry market. One of the major players is F. Hoffman-La Roche AG Company. The F. Hoffman-La Roche AG commanded a share of 23% of the global immunohistochemistry market in 2019. The company is a leading immunohistochemistry product manufacturer and supplies its products to research laboratories, pharmaceutical companies, hospitals, & contract research organizations. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Immunohistochemistry Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Immunohistochemistry Market.

Global Immunohistochemistry Market, Key Highlights:

• Global Immunohistochemistry Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Immunohistochemistry Market • Global Immunohistochemistry Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Immunohistochemistry Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Immunohistochemistry Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Immunohistochemistry Market are also profiled. The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.

Scope of Global Immunohistochemistry Market: Inquire before buying

Global Immunohistochemistry Market, by Product

• Antibodies • Reagents • Equipment • Kits

Global Immunohistochemistry Market, by Application

• Diagnostics o Cancer o Infectious Diseases o Cardiovascular diseases o Autoimmune Diseases o Diabetes mellitus o Nephrological Diseases • Drug Testing

Global Immunohistochemistry Market, by End User

• Hospitals and Diagnostic Laboratories • Research Institutes • Other

Global Immunohistochemistry Market, Key Players

• F. Hoffmann-LA Roche AG • Danaher Corporation • Agilent Technologies, Inc. • Thermo Fisher Scientific Inc. • Merck Millipore • Bio-Rad Laboratories, Inc. • Perkinelmer, Inc. • Abcam PLC • Cell Signaling Technology, Inc. • Bio SB • Shimadzu Corporation • Qiagen N.V. • PerkinElmer, Inc. • Abbott Diagnostics • Meridian Life Science, Inc. • SDIX, LLC • A.G. Scientific, Inc. • Gallus Immunotech, Inc. • Lonza Biologics Ltd. • Takara Bio, Inc. • Beckman Coulter, Inc. • Promega Corporation • BioMerieux • Wako Pure Chemical Industries Ltd. • Waters Corp.

Global Immunohistochemistry Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Immunohistochemistry Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Immunohistochemistry Market 4.8. Global Immunohistochemistry Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Immunohistochemistry Market Analysis and Forecast 6.1. Global Immunohistochemistry Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Immunohistochemistry Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Immunohistochemistry Market Value Share Analysis, by Product 7.4. Global Immunohistochemistry Market Size (US$ Bn) Forecast, by Product 7.5. Global Immunohistochemistry Market Analysis, by Product 7.6. Global Immunohistochemistry Market Attractiveness Analysis, by Product 8. Global Immunohistochemistry Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Immunohistochemistry Market Value Share Analysis, by End User 8.4. Global Immunohistochemistry Market Size (US$ Bn) Forecast, by End User 8.5. Global Immunohistochemistry Market Analysis, by End User 8.6. Global Immunohistochemistry Market Attractiveness Analysis, by End User 9. Global Immunohistochemistry Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Immunohistochemistry Market Value Share Analysis, by Application 9.4. Global Immunohistochemistry Market Size (US$ Bn) Forecast, by Application 9.5. Global Immunohistochemistry Market Analysis, by Application 9.6. Global Immunohistochemistry Market Attractiveness Analysis, by Application 10. Global Immunohistochemistry Market Analysis, by Region 10.1. Global Immunohistochemistry Market Value Share Analysis, by Region 10.2. Global Immunohistochemistry Market Size (US$ Bn) Forecast, by Region 10.3. Global Immunohistochemistry Market Attractiveness Analysis, by Region 11. North America Immunohistochemistry Market Analysis 11.1. Key Findings 11.2. North America Immunohistochemistry Market Overview 11.3. North America Immunohistochemistry Market Value Share Analysis, by Product 11.4. North America Immunohistochemistry Market Forecast, by Product 11.4.1. Antibodies 11.4.2. Reagents 11.4.3. Equipment 11.4.4. Kits 11.5. North America Immunohistochemistry Market Value Share Analysis, by End User 11.6. North America Immunohistochemistry Market Forecast, by End User 11.6.1. Hospitals and Diagnostic Laboratories 11.6.2. Research Institutes 11.6.3. Others 11.7. North America Immunohistochemistry Market Value Share Analysis, by Application 11.8. North America Immunohistochemistry Market Forecast, by Application 11.8.1. Diagnostics 11.8.1.1. Cancer 11.8.1.2. Infectious Diseases 11.8.1.3. Cardiovascular diseases 11.8.1.4. Autoimmune Diseases 11.8.1.5. Diabetes mellitus 11.8.1.6. Nephrological Diseases 11.8.2. Drug Testing 11.9. North America Immunohistochemistry Market Value Share Analysis, by Country 11.10. North America Immunohistochemistry Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Immunohistochemistry Market Analysis, by Country 11.12. U.S. Immunohistochemistry Market Forecast, by Product 11.12.1. Antibodies 11.12.2. Reagents 11.12.3. Equipment 11.12.4. Kits 11.13. U.S. Immunohistochemistry Market Forecast, by End User 11.13.1. Hospitals and Diagnostic Laboratories 11.13.2. Research Institutes 11.13.3. Others 11.14. U.S. Immunohistochemistry Market Forecast, by Application 11.14.1. Diagnostics 11.14.1.1. Cancer 11.14.1.2. Infectious Diseases 11.14.1.3. Cardiovascular diseases 11.14.1.4. Autoimmune Diseases 11.14.1.5. Diabetes mellitus 11.14.1.6. Nephrological Diseases 11.14.2. Drug Testing 11.15. Canada Immunohistochemistry Market Forecast, by Product 11.15.1. Antibodies 11.15.2. Reagents 11.15.3. Equipment 11.15.4. Kits 11.16. Canada Immunohistochemistry Market Forecast, by End User 11.16.1. Hospitals and Diagnostic Laboratories 11.16.2. Research Institutes 11.16.3. Others 11.17. Canada Immunohistochemistry Market Forecast, by Application 11.17.1. Diagnostics 11.17.1.1. Cancer 11.17.1.2. Infectious Diseases 11.17.1.3. Cardiovascular diseases 11.17.1.4. Autoimmune Diseases 11.17.1.5. Diabetes mellitus 11.17.1.6. Nephrological Diseases 11.17.2. Drug Testing 11.18. North America Immunohistochemistry Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By End User 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Immunohistochemistry Market Analysis 12.1. Key Findings 12.2. Europe Immunohistochemistry Market Overview 12.3. Europe Immunohistochemistry Market Value Share Analysis, by Product 12.4. Europe Immunohistochemistry Market Forecast, by Product 12.4.1. Antibodies 12.4.2. Reagents 12.4.3. Equipment 12.4.4. Kits 12.5. Europe Immunohistochemistry Market Value Share Analysis, by End User 12.6. Europe Immunohistochemistry Market Forecast, by End User 12.6.1. Hospitals and Diagnostic Laboratories 12.6.2. Research Institutes 12.6.3. Others 12.7. Europe Immunohistochemistry Market Value Share Analysis, by Application 12.8. Europe Immunohistochemistry Market Forecast, by Application 12.8.1. Diagnostics 12.8.1.1. Cancer 12.8.1.2. Infectious Diseases 12.8.1.3. Cardiovascular diseases 12.8.1.4. Autoimmune Diseases 12.8.1.5. Diabetes mellitus 12.8.1.6. Nephrological Diseases 12.8.2. Drug Testing 12.9. Europe Immunohistochemistry Market Value Share Analysis, by Country 12.10. Europe Immunohistochemistry Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Immunohistochemistry Market Analysis, by Country 12.12. Germany Immunohistochemistry Market Forecast, by Product 12.12.1. Antibodies 12.12.2. Reagents 12.12.3. Equipment 12.12.4. Kits 12.13. Germany Immunohistochemistry Market Forecast, by End User 12.13.1. Hospitals and Diagnostic Laboratories 12.13.2. Research Institutes 12.13.3. Others 12.14. Germany Immunohistochemistry Market Forecast, by Application 12.14.1. Diagnostics 12.14.1.1. Cancer 12.14.1.2. Infectious Diseases 12.14.1.3. Cardiovascular diseases 12.14.1.4. Autoimmune Diseases 12.14.1.5. Diabetes mellitus 12.14.1.6. Nephrological Diseases 12.14.2. Drug Testing 12.15. U.K. Immunohistochemistry Market Forecast, by Product 12.15.1. Antibodies 12.15.2. Reagents 12.15.3. Equipment 12.15.4. Kits 12.16. U.K. Immunohistochemistry Market Forecast, by End User 12.16.1. Hospitals and Diagnostic Laboratories 12.16.2. Research Institutes 12.16.3. Others 12.17. U.K. Immunohistochemistry Market Forecast, by Application 12.17.1. Diagnostics 12.17.1.1. Cancer 12.17.1.2. Infectious Diseases 12.17.1.3. Cardiovascular diseases 12.17.1.4. Autoimmune Diseases 12.17.1.5. Diabetes mellitus 12.17.1.6. Nephrological Diseases 12.17.2. Drug Testing 12.18. France Immunohistochemistry Market Forecast, by Product 12.18.1. Antibodies 12.18.2. Reagents 12.18.3. Equipment 12.18.4. Kits 12.19. France Immunohistochemistry Market Forecast, by End User 12.19.1. Hospitals and Diagnostic Laboratories 12.19.2. Research Institutes 12.19.3. Others 12.20. France Immunohistochemistry Market Forecast, by Application 12.20.1. Diagnostics 12.20.1.1. Cancer 12.20.1.2. Infectious Diseases 12.20.1.3. Cardiovascular diseases 12.20.1.4. Autoimmune Diseases 12.20.1.5. Diabetes mellitus 12.20.1.6. Nephrological Diseases 12.20.2. Drug Testing 12.21. Italy Immunohistochemistry Market Forecast, by Product 12.21.1. Antibodies 12.21.2. Reagents 12.21.3. Equipment 12.21.4. Kits 12.22. Italy Immunohistochemistry Market Forecast, by End User 12.22.1. Hospitals and Diagnostic Laboratories 12.22.2. Research Institutes 12.22.3. Others 12.23. Italy Immunohistochemistry Market Forecast, by Application 12.23.1. Diagnostics 12.23.1.1. Cancer 12.23.1.2. Infectious Diseases 12.23.1.3. Cardiovascular diseases 12.23.1.4. Autoimmune Diseases 12.23.1.5. Diabetes mellitus 12.23.1.6. Nephrological Diseases 12.23.2. Drug Testing 12.24. Spain Immunohistochemistry Market Forecast, by Product 12.24.1. Antibodies 12.24.2. Reagents 12.24.3. Equipment 12.24.4. Kits 12.25. Spain Immunohistochemistry Market Forecast, by End User 12.25.1. Hospitals and Diagnostic Laboratories 12.25.2. Research Institutes 12.25.3. Others 12.26. Spain Immunohistochemistry Market Forecast, by Application 12.26.1. Diagnostics 12.26.1.1. Cancer 12.26.1.2. Infectious Diseases 12.26.1.3. Cardiovascular diseases 12.26.1.4. Autoimmune Diseases 12.26.1.5. Diabetes mellitus 12.26.1.6. Nephrological Diseases 12.26.2. Drug Testing 12.27. Rest of Europe Immunohistochemistry Market Forecast, by Product 12.27.1. Antibodies 12.27.2. Reagents 12.27.3. Equipment 12.27.4. Kits 12.28. Rest of Europe Immunohistochemistry Market Forecast, by End User 12.28.1. Hospitals and Diagnostic Laboratories 12.28.2. Research Institutes 12.28.3. Others 12.29. Rest Of Europe Immunohistochemistry Market Forecast, by Application 12.29.1. Diagnostics 12.29.1.1. Cancer 12.29.1.2. Infectious Diseases 12.29.1.3. Cardiovascular diseases 12.29.1.4. Autoimmune Diseases 12.29.1.5. Diabetes mellitus 12.29.1.6. Nephrological Diseases 12.29.2. Drug Testing 12.30. Europe Immunohistochemistry Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By End User 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Immunohistochemistry Market Analysis 13.1. Key Findings 13.2. Asia Pacific Immunohistochemistry Market Overview 13.3. Asia Pacific Immunohistochemistry Market Value Share Analysis, by Product 13.4. Asia Pacific Immunohistochemistry Market Forecast, by Product 13.4.1. Antibodies 13.4.2. Reagents 13.4.3. Equipment 13.4.4. Kits 13.5. Asia Pacific Immunohistochemistry Market Value Share Analysis, by End User 13.6. Asia Pacific Immunohistochemistry Market Forecast, by End User 13.6.1. Hospitals and Diagnostic Laboratories 13.6.2. Research Institutes 13.6.3. Others 13.7. Asia Pacific Immunohistochemistry Market Value Share Analysis, by Application 13.8. Asia Pacific Immunohistochemistry Market Forecast, by Application 13.8.1. Diagnostics 13.8.1.1. Cancer 13.8.1.2. Infectious Diseases 13.8.1.3. Cardiovascular diseases 13.8.1.4. Autoimmune Diseases 13.8.1.5. Diabetes mellitus 13.8.1.6. Nephrological Diseases 13.8.2. Drug Testing 13.9. Asia Pacific Immunohistochemistry Market Value Share Analysis, by Country 13.10. Asia Pacific Immunohistochemistry Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Immunohistochemistry Market Analysis, by Country 13.12. China Immunohistochemistry Market Forecast, by Product 13.12.1. Antibodies 13.12.2. Reagents 13.12.3. Equipment 13.12.4. Kits 13.13. China Immunohistochemistry Market Forecast, by End User 13.13.1. Hospitals and Diagnostic Laboratories 13.13.2. Research Institutes 13.13.3. Others 13.14. China Immunohistochemistry Market Forecast, by Application 13.14.1. Diagnostics 13.14.1.1. Cancer 13.14.1.2. Infectious Diseases 13.14.1.3. Cardiovascular diseases 13.14.1.4. Autoimmune Diseases 13.14.1.5. Diabetes mellitus 13.14.1.6. Nephrological Diseases 13.14.2. Drug Testing 13.15. India Immunohistochemistry Market Forecast, by Product 13.15.1. Antibodies 13.15.2. Reagents 13.15.3. Equipment 13.15.4. Kits 13.16. India Immunohistochemistry Market Forecast, by End User 13.16.1. Hospitals and Diagnostic Laboratories 13.16.2. Research Institutes 13.16.3. Others 13.17. India Immunohistochemistry Market Forecast, by Application 13.17.1. Diagnostics 13.17.1.1. Cancer 13.17.1.2. Infectious Diseases 13.17.1.3. Cardiovascular diseases 13.17.1.4. Autoimmune Diseases 13.17.1.5. Diabetes mellitus 13.17.1.6. Nephrological Diseases 13.17.2. Drug Testing 13.18. Japan Immunohistochemistry Market Forecast, by Product 13.18.1. Antibodies 13.18.2. Reagents 13.18.3. Equipment 13.18.4. Kits 13.19. Japan Immunohistochemistry Market Forecast, by End User 13.19.1. Hospitals and Diagnostic Laboratories 13.19.2. Research Institutes 13.19.3. Others 13.20. Japan Immunohistochemistry Market Forecast, by Application 13.20.1. Diagnostics 13.20.1.1. Cancer 13.20.1.2. Infectious Diseases 13.20.1.3. Cardiovascular diseases 13.20.1.4. Autoimmune Diseases 13.20.1.5. Diabetes mellitus 13.20.1.6. Nephrological Diseases 13.20.2. Drug Testing 13.21. ASEAN Immunohistochemistry Market Forecast, by Product 13.21.1. Antibodies 13.21.2. Reagents 13.21.3. Equipment 13.21.4. Kits 13.22. ASEAN Immunohistochemistry Market Forecast, by End User 13.22.1. Hospitals and Diagnostic Laboratories 13.22.2. Research Institutes 13.22.3. Others 13.23. ASEAN Immunohistochemistry Market Forecast, by Application 13.23.1. Diagnostics 13.23.1.1. Cancer 13.23.1.2. Infectious Diseases 13.23.1.3. Cardiovascular diseases 13.23.1.4. Autoimmune Diseases 13.23.1.5. Diabetes mellitus 13.23.1.6. Nephrological Diseases 13.23.2. Drug Testing 13.24. Rest of Asia Pacific Immunohistochemistry Market Forecast, by Product 13.24.1. Antibodies 13.24.2. Reagents 13.24.3. Equipment 13.24.4. Kits 13.25. Rest of Asia Pacific Immunohistochemistry Market Forecast, by End User 13.25.1. Hospitals and Diagnostic Laboratories 13.25.2. Research Institutes 13.25.3. Others 13.26. Rest of Asia Pacific Immunohistochemistry Market Forecast, by Application 13.26.1. Diagnostics 13.26.1.1. Cancer 13.26.1.2. Infectious Diseases 13.26.1.3. Cardiovascular diseases 13.26.1.4. Autoimmune Diseases 13.26.1.5. Diabetes mellitus 13.26.1.6. Nephrological Diseases 13.26.2. Drug Testing 13.27. Asia Pacific Immunohistochemistry Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By End User 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Immunohistochemistry Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Immunohistochemistry Market Overview 14.3. Middle East & Africa Immunohistochemistry Market Value Share Analysis, by Product 14.4. Middle East & Africa Immunohistochemistry Market Forecast, by Product 14.4.1. Antibodies 14.4.2. Reagents 14.4.3. Equipment 14.4.4. Kits 14.5. Middle East & Africa Immunohistochemistry Market Value Share Analysis, by End User 14.6. Middle East & Africa Immunohistochemistry Market Forecast, by End User 14.6.1. Hospitals and Diagnostic Laboratories 14.6.2. Research Institutes 14.6.3. Others 14.7. Middle East & Africa Immunohistochemistry Market Value Share Analysis, by Application 14.8. Middle East & Africa Immunohistochemistry Market Forecast, by Application 14.8.1. Diagnostics 14.8.1.1. Cancer 14.8.1.2. Infectious Diseases 14.8.1.3. Cardiovascular diseases 14.8.1.4. Autoimmune Diseases 14.8.1.5. Diabetes mellitus 14.8.1.6. Nephrological Diseases 14.8.2. Drug Testing 14.9. Middle East & Africa Immunohistochemistry Market Value Share Analysis, by Country 14.10. Middle East & Africa Immunohistochemistry Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Immunohistochemistry Market Analysis, by Country 14.12. GCC Immunohistochemistry Market Forecast, by Product 14.12.1. Antibodies 14.12.2. Reagents 14.12.3. Equipment 14.12.4. Kits 14.13. GCC Immunohistochemistry Market Forecast, by End User 14.13.1. Hospitals and Diagnostic Laboratories 14.13.2. Research Institutes 14.13.3. Others 14.14. GCC Immunohistochemistry Market Forecast, by Application 14.14.1. Diagnostics 14.14.1.1. Cancer 14.14.1.2. Infectious Diseases 14.14.1.3. Cardiovascular diseases 14.14.1.4. Autoimmune Diseases 14.14.1.5. Diabetes mellitus 14.14.1.6. Nephrological Diseases 14.14.2. Drug Testing 14.15. South Africa Immunohistochemistry Market Forecast, by Product 14.15.1. Antibodies 14.15.2. Reagents 14.15.3. Equipment 14.15.4. Kits 14.16. South Africa Immunohistochemistry Market Forecast, by End User 14.16.1. Hospitals and Diagnostic Laboratories 14.16.2. Research Institutes 14.16.3. Others 14.17. South Africa Immunohistochemistry Market Forecast, by Application 14.17.1. Diagnostics 14.17.1.1. Cancer 14.17.1.2. Infectious Diseases 14.17.1.3. Cardiovascular diseases 14.17.1.4. Autoimmune Diseases 14.17.1.5. Diabetes mellitus 14.17.1.6. Nephrological Diseases 14.17.2. Drug Testing 14.18. Rest of Middle East & Africa Immunohistochemistry Market Forecast, by Product 14.18.1. Antibodies 14.18.2. Reagents 14.18.3. Equipment 14.18.4. Kits 14.19. Rest of Middle East & Africa Immunohistochemistry Market Forecast, by End User 14.19.1. Hospitals and Diagnostic Laboratories 14.19.2. Research Institutes 14.19.3. Others 14.20. Rest of Middle East & Africa Immunohistochemistry Market Forecast, by Application 14.20.1. Diagnostics 14.20.1.1. Cancer 14.20.1.2. Infectious Diseases 14.20.1.3. Cardiovascular diseases 14.20.1.4. Autoimmune Diseases 14.20.1.5. Diabetes mellitus 14.20.1.6. Nephrological Diseases 14.20.2. Drug Testing 14.21. Middle East & Africa Immunohistochemistry Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By End User 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Immunohistochemistry Market Analysis 15.1. Key Findings 15.2. South America Immunohistochemistry Market Overview 15.3. South America Immunohistochemistry Market Value Share Analysis, by Product 15.4. South America Immunohistochemistry Market Forecast, by Product 15.4.1. Antibodies 15.4.2. Reagents 15.4.3. Equipment 15.4.4. Kits 15.5. South America Immunohistochemistry Market Value Share Analysis, by End User 15.6. South America Immunohistochemistry Market Forecast, by End User 15.6.1. Hospitals and Diagnostic Laboratories 15.6.2. Research Institutes 15.6.3. Others 15.7. South America Immunohistochemistry Market Value Share Analysis, by Application 15.8. South America Immunohistochemistry Market Forecast, by Application 15.8.1. Diagnostics 15.8.1.1. Cancer 15.8.1.2. Infectious Diseases 15.8.1.3. Cardiovascular diseases 15.8.1.4. Autoimmune Diseases 15.8.1.5. Diabetes mellitus 15.8.1.6. Nephrological Diseases 15.8.2. Drug Testing 15.9. South America Immunohistochemistry Market Value Share Analysis, by Country 15.10. South America Immunohistochemistry Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Immunohistochemistry Market Analysis, by Country 15.12. Brazil Immunohistochemistry Market Forecast, by Product 15.12.1. Antibodies 15.12.2. Reagents 15.12.3. Equipment 15.12.4. Kits 15.13. Brazil Immunohistochemistry Market Forecast, by End User 15.13.1. Hospitals and Diagnostic Laboratories 15.13.2. Research Institutes 15.13.3. Others 15.14. Brazil Immunohistochemistry Market Forecast, by Application 15.14.1. Diagnostics 15.14.1.1. Cancer 15.14.1.2. Infectious Diseases 15.14.1.3. Cardiovascular diseases 15.14.1.4. Autoimmune Diseases 15.14.1.5. Diabetes mellitus 15.14.1.6. Nephrological Diseases 15.14.2. Drug Testing 15.15. Mexico Immunohistochemistry Market Forecast, by Product 15.15.1. Antibodies 15.15.2. Reagents 15.15.3. Equipment 15.15.4. Kits 15.16. Mexico Immunohistochemistry Market Forecast, by End User 15.16.1. Hospitals and Diagnostic Laboratories 15.16.2. Research Institutes 15.16.3. Others 15.17. Mexico Immunohistochemistry Market Forecast, by Application 15.17.1. Diagnostics 15.17.1.1. Cancer 15.17.1.2. Infectious Diseases 15.17.1.3. Cardiovascular diseases 15.17.1.4. Autoimmune Diseases 15.17.1.5. Diabetes mellitus 15.17.1.6. Nephrological Diseases 15.17.2. Drug Testing 15.18. Rest of South America Immunohistochemistry Market Forecast, by Product 15.18.1. Antibodies 15.18.2. Reagents 15.18.3. Equipment 15.18.4. Kits 15.19. Rest of South America Immunohistochemistry Market Forecast, by End User 15.19.1. Hospitals and Diagnostic Laboratories 15.19.2. Research Institutes 15.19.3. Others 15.20. Rest of South America Immunohistochemistry Market Forecast, by Application 15.20.1. Diagnostics 15.20.1.1. Cancer 15.20.1.2. Infectious Diseases 15.20.1.3. Cardiovascular diseases 15.20.1.4. Autoimmune Diseases 15.20.1.5. Diabetes mellitus 15.20.1.6. Nephrological Diseases 15.20.2. Drug Testing 15.21. South America Immunohistochemistry Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By End User 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. F. Hoffmann-LA Roche AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing Footprint 16.3.2. Danaher Corporation 16.3.3. Agilent Technologies, Inc. 16.3.4. Thermo Fisher Scientific Inc. 16.3.5. Merck Millipore 16.3.6. Bio-Rad Laboratories, Inc. 16.3.7. Perkinelmer, Inc. 16.3.8. Abcam PLC 16.3.9. Cell Signaling Technology, Inc. 16.3.10. Bio SB 16.3.11. Shimadzu Corporation 16.3.12. Qiagen N.V. 16.3.13. PerkinElmer, Inc. 16.3.14. Abbott Diagnostics 16.3.15. Meridian Life Science, Inc. 16.3.16. SDIX, LLC 16.3.17. A.G. Scientific, Inc. 16.3.18. Gallus Immunotech, Inc. 16.3.19. Lonza Biologics Ltd. 16.3.20. Takara Bio, Inc. 16.3.21. Beckman Coulter, Inc. 16.3.22. Promega Corporation 16.3.23. BioMerieux 16.3.24. Wako Pure Chemical Industries Ltd. 16.3.25. Waters Corp. 17. Primary Key Insights

About This Report

Report ID29312
Category Healthcare
Published DateApril 2019
Updated DateAug 2020
Contact Us